The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subscription to raise £5 million

24 Mar 2021 07:01

RNS Number : 2583T
Circassia Group Plc
24 March 2021
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

24 March 2021

Circassia Group plc

("Circassia" or the "Company" and, together with its subsidiaries, the "Group")Subscription to raise £5 million

Circassia Group plc today announces that it has entered into subscription agreements (the "Agreements") with three of its major institutional shareholders Harwood Capital, Richard Griffiths and Lombard Odier Asset Management to raise a total of £5 million in gross proceeds (the "Subscription") to provide capital investment, to strengthen the Company's balance sheet and provide it with additional liquidity to supplement the continuance of its operational business within the wider Group.

The Group today also announced its audited results for the 12 months ended 31 December 2020 and a post-period update.

Further details of the Agreements

Under the terms of the Agreements, Lombard Odier Asset Management, North Atlantic Smaller Companies Investment Trust plc (to which Harwood Capital acts as investment manager) and Richard Griffiths have subscribed for a total of 20,000,000 new ordinary shares of 0.08 pence each in Circassia (the "Subscription Shares") at a price of 25p per share. The subscription price represents a discount of approximately 10.7 per cent. to the closing mid-market price on 23 March 2021, the latest practicable date prior to this announcement.

The amounts subscribed by the various parties are set out in the table below:

 

Number of Subscription

Shares

Amount

subscribed

Lombard Odier Asset Management

10,000,000

£2,500,000

Richard Griffiths

6,000,000

£1,500,000

North Atlantic Smaller Companies Investment Trust plc

4,000,000

£1,000,000

 

 

Ian Johnson, Executive Chairman of Circassia, said:

"I am grateful for the support of three of our largest shareholders at this time as we continue to invest in the Niox® business. We have a market leading product for the diagnosis and management of asthma and are committing to our aim of delivering greater value to shareholders."

 

Related Party Transactions

The participation in the Subscription by each of Harwood and Richard Griffiths, both of whom are substantial shareholders as defined in the AIM Rules for Companies (the "AIM Rules"), each constitutes a related party transaction under Rule 13 of the AIM Rules. The independent Directors, being the Board members other than Nicholas Mills, consider, having consulted with N+1 Singer as the Company's nominated adviser, that the terms of the transactions with each of Harwood and Richard Griffiths are fair and reasonable insofar as shareholders are concerned.

Application for Admission

Application has been made to the London Stock Exchange for the Subscription Shares to be admitted to trading on AIM. Admission of and dealings in the Subscription Shares is expected to commence at 8.00 a.m. on 25 March 2021.

Following Admission, the Company will have 417,661,192 Ordinary Shares of 0.08p in issue, each carrying one voting right. No shares are held in treasury.

The above figure may therefore be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

General

All Subscription Shares will be issued credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares, including the right to receive all distributions declared on or after the date on which they are issued.

 

 

-Ends-

For further information, please contact:

Circassia Group plc

 

Ian Johnson, Executive Chairman

 

 

c/o N+1 Singer

Michael Roller, CFO

N+1 Singer (Nominated Adviser and Broker)Aubrey Powell / Jen Boorer / Hannah Woodley

Tel: +44 (0) 20 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUORURASUOUUR
Date   Source Headline
8th Jul 20195:02 pmRNSHolding(s) in Company
5th Jul 201912:07 pmRNSHolding(s) in Company
2nd Jul 20195:56 pmRNSHolding(s) in Company
2nd Jul 20195:56 pmRNSHolding(s) in Company
2nd Jul 20195:55 pmRNSHolding(s) in Company
1st Jul 20194:55 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSTotal Voting Rights
25th Jun 20194:57 pmRNSBlock Listing Application
17th Jun 20194:35 pmRNSPrice Monitoring Extension
7th Jun 20196:00 pmRNSHolding(s) in Company
7th Jun 20194:18 pmRNSResult of AGM
6th Jun 20196:23 pmRNSHolding(s) in Company
6th Jun 20194:11 pmRNSHolding(s) in Company
31st May 20197:00 amRNSTotal Voting Rights
28th May 20195:58 pmRNSHolding(s) in Company
28th May 20195:56 pmRNSHolding(s) in Company
21st May 20199:05 amRNSHolding(s) in Company
14th May 20194:24 pmRNSAnnual report and notice of AGM
8th May 20197:00 amRNSPublication of Tudorza Phase IV ASCENT in JAMA
3rd May 20192:18 pmRNSIssue of Equity
1st May 20197:00 amRNSFinal Results
30th Apr 20197:00 amRNSTotal Voting Rights
15th Apr 201911:55 amRNSHolding(s) in Company
1st Apr 20197:00 amRNSFDA approval of Duaklir for treatment of COPD
29th Mar 20194:40 pmRNSSecond Price Monitoring Extn
29th Mar 20194:35 pmRNSPrice Monitoring Extension
29th Mar 20193:58 pmRNSFDA website posts Duaklir NDA approval
29th Mar 20193:34 pmRNSCircassia announces FDA approval of Tudorza sNDA
29th Mar 20197:00 amRNSTotal Voting Rights
5th Mar 20194:53 pmRNSHolding(s) in Company
4th Mar 20194:04 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSTotal Voting Rights
11th Feb 20195:17 pmRNSHolding(s) in Company
8th Feb 20199:00 amRNSNotice of Results
6th Feb 20194:44 pmRNSHolding(s) in Company
6th Feb 20197:00 amRNSHolding(s) in Company
4th Feb 20195:57 pmRNSHolding(s) in Company
4th Feb 20198:06 amRNSSuccessful FDA Presubmission Meeting for AirNOvent
4th Feb 20198:06 amRNSAdmission to AIM
1st Feb 20194:36 pmRNSPrice Monitoring Extension
1st Feb 20194:03 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTotal Voting Rights
30th Jan 20195:30 pmRNSCircassia Pharmaceuticals
30th Jan 20194:41 pmRNSSecond Price Monitoring Extn
30th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20193:30 pmRNSHolding(s) in Company
28th Jan 20193:30 pmRNSHolding(s) in Company
25th Jan 201911:49 amRNSHolding(s) in Company
24th Jan 20197:00 amRNSCommercial rights acquired from AIT Therapeutics
18th Jan 20192:22 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.